Panoskaltsis, Nicki
Georgia Institute of Technology · Emory University · The Wallace H. Coulter Department of Biomedical Engineering · St Mark's Hospital · Winship Cancer Institute · Imperial College London
3 papers on CoChatORCID 0000-0001-8972-5697
Most cited papers
- Verified
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine
COVID-19 Clinical Research StudiesAutoimmune and Inflammatory Disorders Research
Cited by 2,164
- Verified
Oxidized alginate hydrogels with the GHK peptide enhance cord blood mesenchymal stem cell osteogenesis: A paradigm for metabolomics-based evaluation of biomaterial design
Klontzas, M. E., Reakasame, S., Silva, R., Morais, J. C. F., Vernardis, S., MacFarlane, R. J., Heliotis, M., Tsiridis, E., Panoskaltsis, N., Boccaccini, A. R., et al. (2019) · Acta Biomaterialia
Bone Tissue Engineering MaterialsHydrogels: synthesis, properties, applications
Cited by 77
- Verified
Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm
Panoskaltsis, N., McCarthy, N. E., Stagg, A. J., Mummery, C. J., Husni, M., Arebi, N., Greenstein, D., Price, C. L., Al-Hassi, H. O., Koutinas, M., et al. (2021) · Cancer Immunology, Immunotherapy
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 16
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free